Literature DB >> 19852680

Preclinical models for pulmonary drug delivery.

Cláudia A Fernandes1, Rita Vanbever.   

Abstract

BACKGROUND: The lung comprises an interesting route of administration not only for topical drugs but also for systemically acting drugs. Over the last years, several models have been developed in order to study the efficacy and safety of pulmonary drug delivery.
OBJECTIVE: This review describes relevant drug delivery models for preclinical evaluation of inhaled drug products.
METHODS: Epithelial cell culture models, the isolated perfused lung and in vivo models are reviewed. The suitability and limitations of each method are discussed. This review is mostly based on publications from the last 10 years. RESULTS/
CONCLUSION: Cell cultures are ideal models to compare transport rates of molecules and to study their mechanisms of transepithelial transport. Yet the most complete assessment of pulmonary drug delivery including delivery efficacy and safety remains provided by studies performed in vivo in animal models.

Mesh:

Year:  2009        PMID: 19852680     DOI: 10.1517/17425240903241788

Source DB:  PubMed          Journal:  Expert Opin Drug Deliv        ISSN: 1742-5247            Impact factor:   6.648


  30 in total

1.  Delivery of pDNA Polyplexes to Bronchial and Alveolar Epithelial Cells Using a Mesh Nebulizer.

Authors:  Larissa Gomes Dos Reis; Maree Svolos; Lyn M Moir; Rima Jaber; Norbert Windhab; Paul M Young; Daniela Traini
Journal:  Pharm Res       Date:  2018-11-15       Impact factor: 4.200

2.  Pulmonary Pharmacokinetics of Colistin following Administration of Dry Powder Aerosols in Rats.

Authors:  Yu-Wei Lin; Qi Tony Zhou; Yang Hu; Nikolas J Onufrak; Siping Sun; Jiping Wang; Alan Forrest; Hak-Kim Chan; Jian Li
Journal:  Antimicrob Agents Chemother       Date:  2017-10-24       Impact factor: 5.191

3.  Comparison of intrapulmonary and systemic pharmacokinetics of colistin methanesulfonate (CMS) and colistin after aerosol delivery and intravenous administration of CMS in critically ill patients.

Authors:  Matthieu Boisson; Matthieu Jacobs; Nicolas Grégoire; Patrice Gobin; Sandrine Marchand; William Couet; Olivier Mimoz
Journal:  Antimicrob Agents Chemother       Date:  2014-09-29       Impact factor: 5.191

4.  Aerosol Delivery of siRNA to the Lungs. Part 1: Rationale for Gene Delivery Systems.

Authors:  Susanne R Youngren-Ortiz; Nishant S Gandhi; Laura España-Serrano; Mahavir B Chougule
Journal:  Kona       Date:  2015-09-30       Impact factor: 2.897

5.  Modification of disodium cromoglycate passage across lung epithelium in vitro via incorporation into polymeric microparticles.

Authors:  Mehra Haghi; Rania Salama; Daniela Traini; Mary Bebawy; Paul M Young
Journal:  AAPS J       Date:  2011-12-28       Impact factor: 4.009

6.  Benchmarking of Human Dose Prediction for Inhaled Medicines from Preclinical In Vivo Data.

Authors:  Therese Ericsson; Markus Fridén; Carina Kärrman-Mårdh; Ian Dainty; Ken Grime
Journal:  Pharm Res       Date:  2017-07-06       Impact factor: 4.200

7.  Study of nebulization delivery of aerosolized fluorescent microspheres to the avian respiratory tract.

Authors:  Lisa A Tell; Kimberly Stephens; Stephen V Teague; Kent E Pinkerton; Otto G Raabe
Journal:  Avian Dis       Date:  2012-06       Impact factor: 1.577

Review 8.  Bridging the Gap Between Science and Clinical Efficacy: Physiology, Imaging, and Modeling of Aerosols in the Lung.

Authors:  Chantal Darquenne; John S Fleming; Ira Katz; Andrew R Martin; Jeffry Schroeter; Omar S Usmani; Jose Venegas; Otmar Schmid
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2016-02-01       Impact factor: 2.849

Review 9.  Advanced human-relevant in vitro pulmonary platforms for respiratory therapeutics.

Authors:  Arbel Artzy-Schnirman; Sivan Arber Raviv; Ofri Doppelt Flikshtain; Jeny Shklover; Netanel Korin; Adi Gross; Boaz Mizrahi; Avi Schroeder; Josué Sznitman
Journal:  Adv Drug Deliv Rev       Date:  2021-07-29       Impact factor: 15.470

10.  Nanoparticle surface charge impacts distribution, uptake and lymph node trafficking by pulmonary antigen-presenting cells.

Authors:  Catherine A Fromen; Tojan B Rahhal; Gregory R Robbins; Marc P Kai; Tammy W Shen; J Christopher Luft; Joseph M DeSimone
Journal:  Nanomedicine       Date:  2015-12-01       Impact factor: 5.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.